PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAcurx Pharmaceuticals
Acurx Pharmaceuticals(ACXP)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bevifimod
allergic rhinitis seasonal
,
nasal obstruction
,
sneezing
,
dental anxiety
,
restless legs syndrome
,
spinal cord injuries
,
type 1 diabetes mellitus
,
hiv infections
,
non-small-cell lung carcinoma
,
osteoarthritis
,
breast neoplasms
,
depression
,
neurologic manifestations
,
wounds and injuries
,
central nervous system diseases
,
spinal cord diseases
,
sleep wake disorders
,
inguinal hernia
,
peripheral nervous system diseases
,
radiculopathy
,
psoriasis
,
fibromyalgia
,
healthy volunteers/patients
,
neuralgia
,
partial epilepsies
,
diabetic neuropathies
,
epilepsy
,
pain
,
sleep initiation and maintenance disorders
,
seizures
,
postherpetic neuralgia
,
postoperative pain
,
anxiety disorders
,
low back pain
,
generalized anxiety disorder
,
complex partial epilepsy
,
back pain
,
breast feeding
,
bronchiolitis obliterans syndrome
,
neoplasms
,
bone neoplasms
,
intractable pain
,
phantom limb
,
burns
,
renal insufficiency
,
pharmacovigilance
IBEZAPOLSTAT
clostridium infections
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use